Uncategorized
Ophthotech reports $51.5 million in collaboration revenue for 2015
Ophthotech reported $51.5 million in collaboration revenue in 2015 compared with $41.3 million in 2014, according to a press release. The revenue in both years was primarily attributed to the $50 million enrollment-based milestones achieved in September 2014 and March 2015 under an agreement with Novartis regarding ex-U.S. licensing and commercialization of Fovista (pegpleranib).